Witnessing the stock’s movement on the chart, on May 24, 2023, Boston Scientific Corporation (NYSE: BSX) set off with pace as it heaved 0.83% to $51.93. During the day, the stock rose to $52.31 and sunk to $51.23 before settling in for the price of $51.50 at the close. Taking a more long-term approach, BSX posted a 52-week range of $34.98-$54.17.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 7.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -8.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -35.10%. This publicly-traded company’s shares outstanding now amounts to $1.44 billion, simultaneously with a float of $1.43 billion. The organization now has a market capitalization sitting at $74.38 billion. At the time of writing, stock’s 50-day Moving Average stood at $51.17, while the 200-day Moving Average is $45.68.
Boston Scientific Corporation (BSX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Boston Scientific Corporation’s current insider ownership accounts for 0.20%, in contrast to 94.60% institutional ownership. According to the most recent insider trade that took place on May 16, this organization’s EVP & Group Pres, Cardiology sold 63,339 shares at the rate of 53.60, making the entire transaction reach 3,394,856 in total value, affecting insider ownership by 213,859. Preceding that transaction, on May 15, Company’s EVP, Human Resources sold 11,671 for 53.49, making the whole transaction’s value amount to 624,333. This particular insider is now the holder of 78,110 in total.
Boston Scientific Corporation (BSX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 96.56 per share during the current fiscal year.
Boston Scientific Corporation’s EPS decrease for this current 12-month fiscal period is -35.10% and is forecasted to reach 2.22 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 12.17% through the next 5 years, which can be compared against the -8.40% growth it accomplished over the previous five years trading on the market.
Boston Scientific Corporation (NYSE: BSX) Trading Performance Indicators
Let’s observe the current performance indicators for Boston Scientific Corporation (BSX). It’s Quick Ratio in the last reported quarter now stands at 0.90. The Stock has managed to achieve an average true range (ATR) of 1.00. Alongside those numbers, its PE Ratio stands at $88.62, and its Beta score is 0.79. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.70. Similarly, its price to free cash flow for trailing twelve months is now 62.14.
In the same vein, BSX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.59, a figure that is expected to reach 0.49 in the next quarter, and analysts are predicting that it will be 2.22 at the market close of one year from today.
Technical Analysis of Boston Scientific Corporation (BSX)
Going through the that latest performance of [Boston Scientific Corporation, BSX]. Its last 5-days volume of 9.39 million indicated improvement to the volume of 8.53 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 30.60% While, its Average True Range was 1.01.
Raw Stochastic average of Boston Scientific Corporation (BSX) in the period of the previous 100 days is set at 77.19%, which indicates a major rise in contrast to 26.56% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 22.77% that was higher than 17.94% volatility it exhibited in the past 100-days period.
